TMCI:NASDAQ
Treace Medical Concepts, Inc
$3.85
arrow_downward
-1.03%(-0.040) 1D
Okt 8, 10:12:50 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa TMCI...
Buksan
$3.87
Mataas
$3.87
Mababa
$3.78
Mkt. cap
250.38M
Avg. na dami
234.55K
Dami
19.38K
Mataas nang 52-wk
$7.08
Mababa nang 52-wk
$1.17
EPS
-$0.93
Beta
1.48
Mga natitirang share
65.04M
Bilang ng mga empleyado
450
Buksan
$3.87
Mataas
$3.87
Mababa
$3.78
Mkt. cap
250.38M
Avg. na dami
234.55K
Dami
19.38K
Mataas nang 52-wk
$7.08
Mababa nang 52-wk
$1.17
EPS
-$0.93
Beta
1.48
Mga natitirang share
65.04M
Bilang ng mga empleyado
450
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Benzinga
·
1 araw ang nakalipas
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
https://www.dars.gov.et/
·
1 buwan ang nakalipas
TMCI Q2 2026 Earnings: EPS Beat Drives 6.2% Stock Uptick as Losses Narrow - Earnings Deceleration Risk
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Tungkol sa Treace Medical Concepts, Inc